Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002266153 | SCV002547668 | uncertain significance | not specified | 2022-05-19 | criteria provided, single submitter | clinical testing | Variant summary: TTN c.26125G>T (p.Gly8709Cys) results in a non-conservative amino acid change located in the I-band region of the encoded protein sequence. Three of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8.1e-06 in 246270 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.26125G>T in individuals affected with Limb-Girdle Muscular Dystrophy, Type 2J/TTN-related cardiomyopathies and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Revvity Omics, |
RCV003138139 | SCV003820275 | uncertain significance | not provided | 2022-05-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003138139 | SCV003921736 | uncertain significance | not provided | 2022-10-27 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Missense variant in a gene in which most reported pathogenic variants are truncating/loss of function; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV004529111 | SCV004111416 | uncertain significance | TTN-related disorder | 2023-05-05 | criteria provided, single submitter | clinical testing | The TTN c.29857G>T variant is predicted to result in the amino acid substitution p.Gly9953Cys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0086% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-179569342-C-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |